STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...

Mumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Vishwanath Swarup as Commercial Head - ...

U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...

PORTLAND, IN, UNITED STATES, July 14, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global intelligent asthma monitoring devices market generated $180.5 ...

In an era defined by rapid transformation and limitless possibility, Visionaries of Tomorrow: 2025 Most Influential Voices ...

With half a million people having already received multi-cancer early detection (MCED) screening, patients are and will continue to be asking about these blood tests during their visits, physicians ...

Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus ...

Hiding the Truth, from Farm to Fable,” reveals how the animal agriculture industry shielded itself from scrutiny.

During a live event, Hans Lee, MD, and participants shared their perspectives on current and upcoming treatment approaches in ...

The presented data provides a snapshot of the financial health and recent market performance of key stocks within the NIFTY MIDCAP 150 index.